Liver lipid peroxidation in experimental Escherichia coli peritonitis: The role of myeloperoxidase and nitric oxide inhibition

Medical Science Monitor

Volumn 13, Issue 10, 2007, Pages

  Demir, Melek ^a,b   Kaleli, Ilknur ^a   Demir, Suleyman ^a   Sert, Selahattin ^a   Cevahir, Nural ^a   Yildirim, Umut ^a   Sahin, Barbaros ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

L NAME; Malondialdehyde; Myeloperoxydase; Nitric oxide; Peritonitis

Indexed keywords

MALONALDEHYDE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PERITONITIS; BAGG ALBINO MOUSE; CONTROL GROUP; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; LIPID PEROXIDATION; LIVER; MOUSE; NONHUMAN; PERITONEUM LAVAGE;

ANIMALS; ASCITIC FLUID; ESCHERICHIA COLI; FEMALE; HUMANS; LIPID PEROXIDATION; LIVER; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PERITONITIS; PEROXIDASE;

EID: 35548930823     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Thanopoulou AC, Koskinas JS, Hadziyannis SJ: Spontaneous bacterial peritonitis SBP: clinical, laboratory, and prognostic features a single-center experience. Eur J Int Med, 2002; 13: 194-98
2. Saini S, Gupta N, Aparna L, Griwan MS: Surgical Infections: A Microbiological Study. Braz J Infect Dis, 2004; 8: 118-25
3. Marshall JC. Intra-abdominal infections. Microbes and Infection, 2004; 6: 1015-25
4. Dedon PC, Tannenbaum SR: Reactive nitrogen species in the chemical biology of inflammation. Arc Biochem Biophys, 2004; 423: 12-22
5. Victor VM, Rocha M, De la Fuente M: Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol, 2004; 4: 327-47
6. Sethi S, Dikshit M: Modulation of Polymorphonuclear Leukocytes Function by Nitric Oxide. Thromb Res, 2000; 100: 223-47
7. Yerer MB, Yapislar H, Aydogan S Lipid peroxidation and deformability of red blood cells in experimental sepsis in rats: The protective effects of melatonin. Clin Hemorheol Microcirc, 2004; 30: 77-82
8. Zaki MH, Akuta T, Akaike T: Nitric oxide-induced nitrative stress involved in microbial pathogenesis. J Pharmacol Sci, 2005; 98: 117-29
9. Broccard A, Hurni JM, Eckert P et al: Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock, 2000; 14: 35-40
10. Strand OA, Leone AM, Giercksky KE et al: NG-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis. Crit Care Med, 1998; 26: 1490-99
11. Sewnath ME, Olszyna DP, Birjmohun R et al: IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol, 2001; 166: 6323-31
12. Knapp S, de Vos AF, Florquin S et al: Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect Immun, 2003; 71: 6747-53
13. Hogaboam CM, Steinhauser ML, Schock H et al: Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1. Infect Immun, 1998; 66: 650-55
14. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides animal tissues by thiobarbituric acid reaction. Anal Biochem, 1979; 95: 351-58
15. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C: Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods, 1990; 24: 285-95
16. Şener G, Jahovic N, Tosun O et al: Melatonin ameliorates ionizing radiation-induced oxidative organ damage in rats. Life Sci, 2003; 74: 563-72
17. Feihl F, Waeber B, Liaudet L: Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther, 2001; 91: 179-213
18. Avontuur JAM, Nolthenius RPT, Buijk SLC et al: Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Chest, 1998; 113: 1640-46
19. Barocelli E, Ballabeni V, Ghizzardi P et al: The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide, 2006; 14: 212-18
20. Ergun Y, Ergun UG, Orhan FO, Kucuk E: Co-administration of a nitric oxide synthase inhibitor and melatonin exerts an additive antidepressant-like effect in the mouse forced swim test. Med Sci Monit, 2006; 12(9): BR307-12
21. Chatterjee PK, Kvale EO, Patel NS, Thiemermann C: GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells. Med Sci Monit, 2003; 9(10): BR357-62
22. Kotsanas D, Polkinghorne KR, Korman TM et al: Risk factors for peritoneal dialysis-related peritonitis: Can we reduce the incidence and improve patient selection? Nephrology, 2007; 12: 239-45
23. Ebisawa Y, Kono T, Yoneda M et al: Direct evidence that induced nitric oxide production in hepatocytes prevents liver damage during lipopolysaccharide tolerance in rats. J Surg Res, 2004; 118: 183-89
24. Ozakyol AH, Tuncel N, Sarýcam T et al: Effect of nitric oxide inhibition on rat liver ischemia reperfusion injury. Pathophysiology, 2000; 7: 183-88
25. Zhang C, Walker LM, Hinson JA, Mayeux PR: Oxidant stress in rat liver after lipopolysaccharide administration: Effect of inducible nitric-oxide synthase inhibition. J Pharmacol Exp Ther, 2000; 293(3): 968-72
26. Saetre T, Gundersen Y, Smiseth OA et al: Hepatic oxygen metabolism in porcine endotoxemia: the effect of nitric oxide synthase inhibition. Am J Physiol, 1998; 275: G1377-85
27. Alexander B: The role of nitric oxide in hepatic metabolism. Nutrition, 1998; 14: 376-90
28. Fukatsu K, Saito H, Han I et al: Nitric Oxide Inhibition Decreases Neutrophil Adhesion at the Inflammatory Site, While Increasing Adhesion in Remote Organs in Peritonitis. J Surg Res, 1997; 68: 79-86
29. Cauwels A, Bultinck J, Brouckaert P: Dual role of endogenous nitric oxide in tumor necrosis factor shock: induced NO tempers oxidative stress. Cell Mol Life Sci, 2005; 62: 1632-40
30. Yao V, McCauley R, Cooper D et al: Myeloperoxidase response to peritonitis in an experimental model. ANZ J Surg; 2003; 73: 1052-56
31. Abu-Soud HM, Hazen SL: Nitric Oxide is a physiological substrate for mammalian peroxidase. J Biol Chem, 2000; 275: 37524-32
32. Zhang R, Brennan ML, Shen Z et al: Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem, 2002; 277: 46116-22
33. Galijasevic S, Saed GM, Diamond MP, Abu-Soud HM: Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. PNAS, 2003; 100: 14766-71
34. Abu-Soud HM, Hazen SL: Nitric Oxide Modulates the Catalytic Activity of Myeloperoxidase. J Biol Chem, 2000; 275: 5425-30
35. Hazen SL, Zhang R, Shen Z et al: Formation of nitric-oxide-derived oxidants by myeloperoxidase in monocytes. Circ Res, 1999; 85: 950-58